Evaluate the Preliminary Efficacy, Safety, and PK of Subcutaneous JS005 in Chinese Adult Patients With Active Nr-axSpA

NCT05242588 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
120
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Junshi Bioscience Co., Ltd.

Collaborators